Four Thought Financial, LLC Chemo Centryx, Inc. Transaction History

Four Thought Financial, LLC

  • $677 Million
  • Q3 2022

A detailed history of Four Thought Financial, LLC transactions in Chemo Centryx, Inc. stock. As of the latest transaction made, Four Thought Financial, LLC holds 24 shares of CCXI stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 24 -0.0%
Holding current value
$0
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022
BUY
$18.38 - $40.5 $441 - $972
24 New
24 $1,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email